0001731122-24-000070.txt : 20240112 0001731122-24-000070.hdr.sgml : 20240112 20240112200046 ACCESSION NUMBER: 0001731122-24-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240112 DATE AS OF CHANGE: 20240112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MISSLING CHRISTOPHER U CENTRAL INDEX KEY: 0001196573 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37606 FILM NUMBER: 24533293 MAIL ADDRESS: STREET 1: 61 MOULTON ST CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANAVEX LIFE SCIENCES CORP. CENTRAL INDEX KEY: 0001314052 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 980608404 FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 630 5TH AVENUE STREET 2: 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10111 BUSINESS PHONE: 844-689-3939 MAIL ADDRESS: STREET 1: 630 5TH AVENUE STREET 2: 20TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10111 FORMER COMPANY: FORMER CONFORMED NAME: Thrifty Printing Inc. DATE OF NAME CHANGE: 20050111 4 1 ownership.xml X0508 4 2024-01-02 1 0001314052 ANAVEX LIFE SCIENCES CORP. AVXL 0001196573 MISSLING CHRISTOPHER U 630 5TH AVENUE, 20TH FLOOR NEW YORK NY 10111 1 1 0 0 President and CEO 0 Stock Option (Right to Buy) 10.09 2024-01-02 4 A 0 125000 0 D 2024-01-02 2032-06-27 Common Stock 125000 125000 D On June 27, 2022, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which included topline data readout of ANAVEX2-73-RS-003 EXCELLENCE clinical trial in Rett Syndrome. The performance criteria for this milestone was met, resulting in vesting of the option as to 125,000 shares. /s/Christopher Missling 2024-01-12